Perphenazine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for perphenazine and what is the scope of freedom to operate?
Perphenazine
is the generic ingredient in two branded drugs marketed by Pharm Assoc, Schering, Ani Pharms, Appco, Mylan, Rising, Sandoz, Vintage Pharms, Watson Labs Inc, Wilshire Pharms Inc, and Zydus Pharms, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for perphenazine. Fifteen suppliers are listed for this compound.
Summary for perphenazine
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 11 |
| NDAs: | 18 |
| Drug Master File Entries: | 8 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 27 |
| Patent Applications: | 7,136 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for perphenazine |
| What excipients (inactive ingredients) are in perphenazine? | perphenazine excipients list |
| DailyMed Link: | perphenazine at DailyMed |
Recent Clinical Trials for perphenazine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institute of Experimental and Clinical Therapeutics | Phase 2 |
| Hospital Civil de Guadalajara | Phase 2 |
| University of Guadalajara | Phase 2 |
Pharmacology for perphenazine
| Drug Class | Phenothiazine |
Medical Subject Heading (MeSH) Categories for perphenazine
Anatomical Therapeutic Chemical (ATC) Classes for perphenazine
US Patents and Regulatory Information for perphenazine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | TRILAFON | perphenazine | INJECTABLE;INJECTION | 011213-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Appco | PERPHENAZINE | perphenazine | TABLET;ORAL | 210163-002 | May 18, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Watson Labs Inc | PERPHENAZINE | perphenazine | TABLET;ORAL | 207582-001 | Oct 17, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Ani Pharms | PERPHENAZINE | perphenazine | TABLET;ORAL | 089708-001 | Sep 10, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
